Research ArticleArticle
Proposed Core Set of Items for Measuring Disease Activity in Systemic Juvenile Idiopathic Arthritis
Elizaveta Limenis, Brian M. Feldman, Camille Achonu, Michelle Batthish, Bianca Lang, Marjorie Mclimont, Sylvia Ota, Athimalaipet Ramanan, Rosie Scuccimarri, Nancy L. Young and Rayfel Schneider
The Journal of Rheumatology August 2017, jrheum.161534; DOI: https://doi.org/10.3899/jrheum.161534
Elizaveta Limenis
From the Hospital for Sick Children, Division of Rheumatology; Dalla Lana School of Public Health, University of Toronto; Public Health Ontario; Toronto Public Health, Toronto; McMaster University, McMaster Children’s Hospital, Hamilton; School of Rural and Northern Health, Laurentian University, Sudbury, Ontario; Dalhousie University, IWK Health Centre, Halifax, Nova Scotia; McGill University, Montreal Children’s Hospital, Montreal, Quebec, Canada; University of Bristol, Bristol Royal Hospital for Children, Bristol, UK. Earlier phase of this study supported by Pfizer Inc. through an unrestricted research grant. E. Limenis, BSc, MD, University of Toronto, Hospital for Sick Children; B.M. Feldman, MD, MSc, FRCPC, University of Toronto, Hospital for Sick Children, Dalla Lana School of Public Health; C. Achonu, BSc, MHSc, Public Health Ontario; M. Batthish, MD, MSc, FRCPC, McMaster University, McMaster Children’s Hospital; B. Lang, MD, FRCPC, Dalhousie University, IWK Health Centre; M. Mclimont, BSc, MSc, Hospital for Sick Children; S. Ota, BSc, MHSc, Toronto Public Health; A. Ramanan, FRCP, University of Bristol, Bristol Royal Hospital for Children; R. Scuccimarri, MD, FRCPC, McGill University, Montreal Children’s Hospital; N.L. Young, BScPT, MSc, PhD, School of Rural and Northern Health, Laurentian University; R. Schneider, MBBCh, FRCPC, University of Toronto, Hospital for Sick Children. Address correspondence to Dr. B.M. Feldman, Division of Rheumatology, The Hospital for Sick Children, 555 University Ave., Toronto, Ontario M5G 1X8, Canada. E-mail: brian.feldman@sickkids.ca. Accepted for publication May 10, 2017.
Brian M. Feldman
From the Hospital for Sick Children, Division of Rheumatology; Dalla Lana School of Public Health, University of Toronto; Public Health Ontario; Toronto Public Health, Toronto; McMaster University, McMaster Children’s Hospital, Hamilton; School of Rural and Northern Health, Laurentian University, Sudbury, Ontario; Dalhousie University, IWK Health Centre, Halifax, Nova Scotia; McGill University, Montreal Children’s Hospital, Montreal, Quebec, Canada; University of Bristol, Bristol Royal Hospital for Children, Bristol, UK. Earlier phase of this study supported by Pfizer Inc. through an unrestricted research grant. E. Limenis, BSc, MD, University of Toronto, Hospital for Sick Children; B.M. Feldman, MD, MSc, FRCPC, University of Toronto, Hospital for Sick Children, Dalla Lana School of Public Health; C. Achonu, BSc, MHSc, Public Health Ontario; M. Batthish, MD, MSc, FRCPC, McMaster University, McMaster Children’s Hospital; B. Lang, MD, FRCPC, Dalhousie University, IWK Health Centre; M. Mclimont, BSc, MSc, Hospital for Sick Children; S. Ota, BSc, MHSc, Toronto Public Health; A. Ramanan, FRCP, University of Bristol, Bristol Royal Hospital for Children; R. Scuccimarri, MD, FRCPC, McGill University, Montreal Children’s Hospital; N.L. Young, BScPT, MSc, PhD, School of Rural and Northern Health, Laurentian University; R. Schneider, MBBCh, FRCPC, University of Toronto, Hospital for Sick Children. Address correspondence to Dr. B.M. Feldman, Division of Rheumatology, The Hospital for Sick Children, 555 University Ave., Toronto, Ontario M5G 1X8, Canada. E-mail: brian.feldman@sickkids.ca. Accepted for publication May 10, 2017.
Camille Achonu
From the Hospital for Sick Children, Division of Rheumatology; Dalla Lana School of Public Health, University of Toronto; Public Health Ontario; Toronto Public Health, Toronto; McMaster University, McMaster Children’s Hospital, Hamilton; School of Rural and Northern Health, Laurentian University, Sudbury, Ontario; Dalhousie University, IWK Health Centre, Halifax, Nova Scotia; McGill University, Montreal Children’s Hospital, Montreal, Quebec, Canada; University of Bristol, Bristol Royal Hospital for Children, Bristol, UK. Earlier phase of this study supported by Pfizer Inc. through an unrestricted research grant. E. Limenis, BSc, MD, University of Toronto, Hospital for Sick Children; B.M. Feldman, MD, MSc, FRCPC, University of Toronto, Hospital for Sick Children, Dalla Lana School of Public Health; C. Achonu, BSc, MHSc, Public Health Ontario; M. Batthish, MD, MSc, FRCPC, McMaster University, McMaster Children’s Hospital; B. Lang, MD, FRCPC, Dalhousie University, IWK Health Centre; M. Mclimont, BSc, MSc, Hospital for Sick Children; S. Ota, BSc, MHSc, Toronto Public Health; A. Ramanan, FRCP, University of Bristol, Bristol Royal Hospital for Children; R. Scuccimarri, MD, FRCPC, McGill University, Montreal Children’s Hospital; N.L. Young, BScPT, MSc, PhD, School of Rural and Northern Health, Laurentian University; R. Schneider, MBBCh, FRCPC, University of Toronto, Hospital for Sick Children. Address correspondence to Dr. B.M. Feldman, Division of Rheumatology, The Hospital for Sick Children, 555 University Ave., Toronto, Ontario M5G 1X8, Canada. E-mail: brian.feldman@sickkids.ca. Accepted for publication May 10, 2017.
Michelle Batthish
From the Hospital for Sick Children, Division of Rheumatology; Dalla Lana School of Public Health, University of Toronto; Public Health Ontario; Toronto Public Health, Toronto; McMaster University, McMaster Children’s Hospital, Hamilton; School of Rural and Northern Health, Laurentian University, Sudbury, Ontario; Dalhousie University, IWK Health Centre, Halifax, Nova Scotia; McGill University, Montreal Children’s Hospital, Montreal, Quebec, Canada; University of Bristol, Bristol Royal Hospital for Children, Bristol, UK. Earlier phase of this study supported by Pfizer Inc. through an unrestricted research grant. E. Limenis, BSc, MD, University of Toronto, Hospital for Sick Children; B.M. Feldman, MD, MSc, FRCPC, University of Toronto, Hospital for Sick Children, Dalla Lana School of Public Health; C. Achonu, BSc, MHSc, Public Health Ontario; M. Batthish, MD, MSc, FRCPC, McMaster University, McMaster Children’s Hospital; B. Lang, MD, FRCPC, Dalhousie University, IWK Health Centre; M. Mclimont, BSc, MSc, Hospital for Sick Children; S. Ota, BSc, MHSc, Toronto Public Health; A. Ramanan, FRCP, University of Bristol, Bristol Royal Hospital for Children; R. Scuccimarri, MD, FRCPC, McGill University, Montreal Children’s Hospital; N.L. Young, BScPT, MSc, PhD, School of Rural and Northern Health, Laurentian University; R. Schneider, MBBCh, FRCPC, University of Toronto, Hospital for Sick Children. Address correspondence to Dr. B.M. Feldman, Division of Rheumatology, The Hospital for Sick Children, 555 University Ave., Toronto, Ontario M5G 1X8, Canada. E-mail: brian.feldman@sickkids.ca. Accepted for publication May 10, 2017.
Bianca Lang
From the Hospital for Sick Children, Division of Rheumatology; Dalla Lana School of Public Health, University of Toronto; Public Health Ontario; Toronto Public Health, Toronto; McMaster University, McMaster Children’s Hospital, Hamilton; School of Rural and Northern Health, Laurentian University, Sudbury, Ontario; Dalhousie University, IWK Health Centre, Halifax, Nova Scotia; McGill University, Montreal Children’s Hospital, Montreal, Quebec, Canada; University of Bristol, Bristol Royal Hospital for Children, Bristol, UK. Earlier phase of this study supported by Pfizer Inc. through an unrestricted research grant. E. Limenis, BSc, MD, University of Toronto, Hospital for Sick Children; B.M. Feldman, MD, MSc, FRCPC, University of Toronto, Hospital for Sick Children, Dalla Lana School of Public Health; C. Achonu, BSc, MHSc, Public Health Ontario; M. Batthish, MD, MSc, FRCPC, McMaster University, McMaster Children’s Hospital; B. Lang, MD, FRCPC, Dalhousie University, IWK Health Centre; M. Mclimont, BSc, MSc, Hospital for Sick Children; S. Ota, BSc, MHSc, Toronto Public Health; A. Ramanan, FRCP, University of Bristol, Bristol Royal Hospital for Children; R. Scuccimarri, MD, FRCPC, McGill University, Montreal Children’s Hospital; N.L. Young, BScPT, MSc, PhD, School of Rural and Northern Health, Laurentian University; R. Schneider, MBBCh, FRCPC, University of Toronto, Hospital for Sick Children. Address correspondence to Dr. B.M. Feldman, Division of Rheumatology, The Hospital for Sick Children, 555 University Ave., Toronto, Ontario M5G 1X8, Canada. E-mail: brian.feldman@sickkids.ca. Accepted for publication May 10, 2017.
Marjorie Mclimont
From the Hospital for Sick Children, Division of Rheumatology; Dalla Lana School of Public Health, University of Toronto; Public Health Ontario; Toronto Public Health, Toronto; McMaster University, McMaster Children’s Hospital, Hamilton; School of Rural and Northern Health, Laurentian University, Sudbury, Ontario; Dalhousie University, IWK Health Centre, Halifax, Nova Scotia; McGill University, Montreal Children’s Hospital, Montreal, Quebec, Canada; University of Bristol, Bristol Royal Hospital for Children, Bristol, UK. Earlier phase of this study supported by Pfizer Inc. through an unrestricted research grant. E. Limenis, BSc, MD, University of Toronto, Hospital for Sick Children; B.M. Feldman, MD, MSc, FRCPC, University of Toronto, Hospital for Sick Children, Dalla Lana School of Public Health; C. Achonu, BSc, MHSc, Public Health Ontario; M. Batthish, MD, MSc, FRCPC, McMaster University, McMaster Children’s Hospital; B. Lang, MD, FRCPC, Dalhousie University, IWK Health Centre; M. Mclimont, BSc, MSc, Hospital for Sick Children; S. Ota, BSc, MHSc, Toronto Public Health; A. Ramanan, FRCP, University of Bristol, Bristol Royal Hospital for Children; R. Scuccimarri, MD, FRCPC, McGill University, Montreal Children’s Hospital; N.L. Young, BScPT, MSc, PhD, School of Rural and Northern Health, Laurentian University; R. Schneider, MBBCh, FRCPC, University of Toronto, Hospital for Sick Children. Address correspondence to Dr. B.M. Feldman, Division of Rheumatology, The Hospital for Sick Children, 555 University Ave., Toronto, Ontario M5G 1X8, Canada. E-mail: brian.feldman@sickkids.ca. Accepted for publication May 10, 2017.
Sylvia Ota
From the Hospital for Sick Children, Division of Rheumatology; Dalla Lana School of Public Health, University of Toronto; Public Health Ontario; Toronto Public Health, Toronto; McMaster University, McMaster Children’s Hospital, Hamilton; School of Rural and Northern Health, Laurentian University, Sudbury, Ontario; Dalhousie University, IWK Health Centre, Halifax, Nova Scotia; McGill University, Montreal Children’s Hospital, Montreal, Quebec, Canada; University of Bristol, Bristol Royal Hospital for Children, Bristol, UK. Earlier phase of this study supported by Pfizer Inc. through an unrestricted research grant. E. Limenis, BSc, MD, University of Toronto, Hospital for Sick Children; B.M. Feldman, MD, MSc, FRCPC, University of Toronto, Hospital for Sick Children, Dalla Lana School of Public Health; C. Achonu, BSc, MHSc, Public Health Ontario; M. Batthish, MD, MSc, FRCPC, McMaster University, McMaster Children’s Hospital; B. Lang, MD, FRCPC, Dalhousie University, IWK Health Centre; M. Mclimont, BSc, MSc, Hospital for Sick Children; S. Ota, BSc, MHSc, Toronto Public Health; A. Ramanan, FRCP, University of Bristol, Bristol Royal Hospital for Children; R. Scuccimarri, MD, FRCPC, McGill University, Montreal Children’s Hospital; N.L. Young, BScPT, MSc, PhD, School of Rural and Northern Health, Laurentian University; R. Schneider, MBBCh, FRCPC, University of Toronto, Hospital for Sick Children. Address correspondence to Dr. B.M. Feldman, Division of Rheumatology, The Hospital for Sick Children, 555 University Ave., Toronto, Ontario M5G 1X8, Canada. E-mail: brian.feldman@sickkids.ca. Accepted for publication May 10, 2017.
Athimalaipet Ramanan
From the Hospital for Sick Children, Division of Rheumatology; Dalla Lana School of Public Health, University of Toronto; Public Health Ontario; Toronto Public Health, Toronto; McMaster University, McMaster Children’s Hospital, Hamilton; School of Rural and Northern Health, Laurentian University, Sudbury, Ontario; Dalhousie University, IWK Health Centre, Halifax, Nova Scotia; McGill University, Montreal Children’s Hospital, Montreal, Quebec, Canada; University of Bristol, Bristol Royal Hospital for Children, Bristol, UK. Earlier phase of this study supported by Pfizer Inc. through an unrestricted research grant. E. Limenis, BSc, MD, University of Toronto, Hospital for Sick Children; B.M. Feldman, MD, MSc, FRCPC, University of Toronto, Hospital for Sick Children, Dalla Lana School of Public Health; C. Achonu, BSc, MHSc, Public Health Ontario; M. Batthish, MD, MSc, FRCPC, McMaster University, McMaster Children’s Hospital; B. Lang, MD, FRCPC, Dalhousie University, IWK Health Centre; M. Mclimont, BSc, MSc, Hospital for Sick Children; S. Ota, BSc, MHSc, Toronto Public Health; A. Ramanan, FRCP, University of Bristol, Bristol Royal Hospital for Children; R. Scuccimarri, MD, FRCPC, McGill University, Montreal Children’s Hospital; N.L. Young, BScPT, MSc, PhD, School of Rural and Northern Health, Laurentian University; R. Schneider, MBBCh, FRCPC, University of Toronto, Hospital for Sick Children. Address correspondence to Dr. B.M. Feldman, Division of Rheumatology, The Hospital for Sick Children, 555 University Ave., Toronto, Ontario M5G 1X8, Canada. E-mail: brian.feldman@sickkids.ca. Accepted for publication May 10, 2017.
Rosie Scuccimarri
From the Hospital for Sick Children, Division of Rheumatology; Dalla Lana School of Public Health, University of Toronto; Public Health Ontario; Toronto Public Health, Toronto; McMaster University, McMaster Children’s Hospital, Hamilton; School of Rural and Northern Health, Laurentian University, Sudbury, Ontario; Dalhousie University, IWK Health Centre, Halifax, Nova Scotia; McGill University, Montreal Children’s Hospital, Montreal, Quebec, Canada; University of Bristol, Bristol Royal Hospital for Children, Bristol, UK. Earlier phase of this study supported by Pfizer Inc. through an unrestricted research grant. E. Limenis, BSc, MD, University of Toronto, Hospital for Sick Children; B.M. Feldman, MD, MSc, FRCPC, University of Toronto, Hospital for Sick Children, Dalla Lana School of Public Health; C. Achonu, BSc, MHSc, Public Health Ontario; M. Batthish, MD, MSc, FRCPC, McMaster University, McMaster Children’s Hospital; B. Lang, MD, FRCPC, Dalhousie University, IWK Health Centre; M. Mclimont, BSc, MSc, Hospital for Sick Children; S. Ota, BSc, MHSc, Toronto Public Health; A. Ramanan, FRCP, University of Bristol, Bristol Royal Hospital for Children; R. Scuccimarri, MD, FRCPC, McGill University, Montreal Children’s Hospital; N.L. Young, BScPT, MSc, PhD, School of Rural and Northern Health, Laurentian University; R. Schneider, MBBCh, FRCPC, University of Toronto, Hospital for Sick Children. Address correspondence to Dr. B.M. Feldman, Division of Rheumatology, The Hospital for Sick Children, 555 University Ave., Toronto, Ontario M5G 1X8, Canada. E-mail: brian.feldman@sickkids.ca. Accepted for publication May 10, 2017.
Nancy L. Young
From the Hospital for Sick Children, Division of Rheumatology; Dalla Lana School of Public Health, University of Toronto; Public Health Ontario; Toronto Public Health, Toronto; McMaster University, McMaster Children’s Hospital, Hamilton; School of Rural and Northern Health, Laurentian University, Sudbury, Ontario; Dalhousie University, IWK Health Centre, Halifax, Nova Scotia; McGill University, Montreal Children’s Hospital, Montreal, Quebec, Canada; University of Bristol, Bristol Royal Hospital for Children, Bristol, UK. Earlier phase of this study supported by Pfizer Inc. through an unrestricted research grant. E. Limenis, BSc, MD, University of Toronto, Hospital for Sick Children; B.M. Feldman, MD, MSc, FRCPC, University of Toronto, Hospital for Sick Children, Dalla Lana School of Public Health; C. Achonu, BSc, MHSc, Public Health Ontario; M. Batthish, MD, MSc, FRCPC, McMaster University, McMaster Children’s Hospital; B. Lang, MD, FRCPC, Dalhousie University, IWK Health Centre; M. Mclimont, BSc, MSc, Hospital for Sick Children; S. Ota, BSc, MHSc, Toronto Public Health; A. Ramanan, FRCP, University of Bristol, Bristol Royal Hospital for Children; R. Scuccimarri, MD, FRCPC, McGill University, Montreal Children’s Hospital; N.L. Young, BScPT, MSc, PhD, School of Rural and Northern Health, Laurentian University; R. Schneider, MBBCh, FRCPC, University of Toronto, Hospital for Sick Children. Address correspondence to Dr. B.M. Feldman, Division of Rheumatology, The Hospital for Sick Children, 555 University Ave., Toronto, Ontario M5G 1X8, Canada. E-mail: brian.feldman@sickkids.ca. Accepted for publication May 10, 2017.
Rayfel Schneider
From the Hospital for Sick Children, Division of Rheumatology; Dalla Lana School of Public Health, University of Toronto; Public Health Ontario; Toronto Public Health, Toronto; McMaster University, McMaster Children’s Hospital, Hamilton; School of Rural and Northern Health, Laurentian University, Sudbury, Ontario; Dalhousie University, IWK Health Centre, Halifax, Nova Scotia; McGill University, Montreal Children’s Hospital, Montreal, Quebec, Canada; University of Bristol, Bristol Royal Hospital for Children, Bristol, UK. Earlier phase of this study supported by Pfizer Inc. through an unrestricted research grant. E. Limenis, BSc, MD, University of Toronto, Hospital for Sick Children; B.M. Feldman, MD, MSc, FRCPC, University of Toronto, Hospital for Sick Children, Dalla Lana School of Public Health; C. Achonu, BSc, MHSc, Public Health Ontario; M. Batthish, MD, MSc, FRCPC, McMaster University, McMaster Children’s Hospital; B. Lang, MD, FRCPC, Dalhousie University, IWK Health Centre; M. Mclimont, BSc, MSc, Hospital for Sick Children; S. Ota, BSc, MHSc, Toronto Public Health; A. Ramanan, FRCP, University of Bristol, Bristol Royal Hospital for Children; R. Scuccimarri, MD, FRCPC, McGill University, Montreal Children’s Hospital; N.L. Young, BScPT, MSc, PhD, School of Rural and Northern Health, Laurentian University; R. Schneider, MBBCh, FRCPC, University of Toronto, Hospital for Sick Children. Address correspondence to Dr. B.M. Feldman, Division of Rheumatology, The Hospital for Sick Children, 555 University Ave., Toronto, Ontario M5G 1X8, Canada. E-mail: brian.feldman@sickkids.ca. Accepted for publication May 10, 2017.
Article Figures & Data
Additional Files
Data Supplement
Files in this Data Supplement:
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Proposed Core Set of Items for Measuring Disease Activity in Systemic Juvenile Idiopathic Arthritis
Elizaveta Limenis, Brian M. Feldman, Camille Achonu, Michelle Batthish, Bianca Lang, Marjorie Mclimont, Sylvia Ota, Athimalaipet Ramanan, Rosie Scuccimarri, Nancy L. Young, Rayfel Schneider
The Journal of Rheumatology Aug 2017, jrheum.161534; DOI: 10.3899/jrheum.161534
Proposed Core Set of Items for Measuring Disease Activity in Systemic Juvenile Idiopathic Arthritis
Elizaveta Limenis, Brian M. Feldman, Camille Achonu, Michelle Batthish, Bianca Lang, Marjorie Mclimont, Sylvia Ota, Athimalaipet Ramanan, Rosie Scuccimarri, Nancy L. Young, Rayfel Schneider
The Journal of Rheumatology Aug 2017, jrheum.161534; DOI: 10.3899/jrheum.161534